The legislation establishes policies on “healing centers” where adults 21 and older will be able to receive psychedelic treatment; tightens up rules on cultivation and facilitators; creates licensing requirements; dictates state agency regulatory responsibilities; and imposes penalties for unsanctioned activities.
this post was submitted on 04 Jun 2023
14 points (100.0% liked)
World News
22083 readers
12 users here now
Breaking news from around the world.
News that is American but has an international facet may also be posted here.
Guidelines for submissions:
- Where possible, post the original source of information.
- If there is a paywall, you can use alternative sources or provide an archive.today, 12ft.io, etc. link in the body.
- Do not editorialize titles. Preserve the original title when possible; edits for clarity are fine.
- Do not post ragebait or shock stories. These will be removed.
- Do not post tabloid or blogspam stories. These will be removed.
- Social media should be a source of last resort.
These guidelines will be enforced on a know-it-when-I-see-it basis.
For US News, see the US News community.
This community's icon was made by Aaron Schneider, under the CC-BY-NC-SA 4.0 license.
founded 2 years ago
MODERATORS
This is super exciting. I'm so glad some states and Canada are decriminalizing psychedelics instead of furthering the harm of the war on drugs. Hopefully it'll mirror cannabis legalization and will be available in most states a decade from now.
yeah! the colorado legislation here is also exciting specifically because it (and the referendum which originally made all this possible) names more than just psilocybin for decriminalization among the psychedelics. they made it possible for ibogaine to immediately be administered, and eventually DMT and mescaline will also be covered:
- Initially only psilocybin and psilocyn can be administered at healing centers, but regulators can later add additional psychedelics. The bill differs from the ballot measure by making it so regulators will be able to authorize the supervised use of ibogaine at the facilities at any time, rather than waiting until at least June 1, 2026, as is the case for mescaline and DMT.